OBI Pharma, Inc. (4174)
Market Closed
16 Oct, 05:30 AM
TWSE 
JPX Primary TWSE NT$
56. 90
-3
-5.0083%
NT$
- Market Cap
- P/E Ratio
32% Div Yield
2.74M Volume
- Eps
NT$ 59.9
Previous Close Want to track 4174 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
OBI Pharma, Inc. (4174) Statistics
Valuation metrics
Market Cap -
Enterprise value 7.62B
Trailing P/E (ttm) -2.09
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 143.42
Price/Book (mrq) 5.03
Enterprise Value/Revenue 145.96
Enterprise Value/EBITDA -5.51
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.41M
Average volume (90 days) 843.55K
Price summary
52-Week low 24.3
52-Week high 66.8
Beta -
50-Day moving average 36.07
200-Day moving average 31.66
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 30 Jul 2026
Ex-Dividend Date 30 Jul 2026
Last split factor 500:1,000
Last split Date 27 Jan 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -29.23%
Operating margin -31.4%
Operational effectiveness
Return on assets -0.57%
Return on equity -0.87%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.4
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -11.6
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.78
Total debt (mrq) -
Total Debt/Equity (mrq) 0.3
Current ratio (mrq) 3.7%
Book value per share (mrq) 16.68
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
